consensu
statement
american
colleg
veterinari
intern
medicin
acvim
provid
veterinari
commun
uptod
inform
pathophysiolog
diagnosi
treatment
clinic
import
anim
diseas
acvim
board
regent
overse
select
relev
topic
identif
panel
member
expertis
draft
statement
aspect
assur
integr
process
statement
deriv
evidencebas
medicin
whenev
possibl
panel
offer
interpret
comment
evid
inadequ
contradictori
draft
prepar
panel
follow
solicit
input
acvim
membership
may
incorpor
statement
submit
journal
veterinari
intern
medicin
edit
public
author
sole
respons
content
statement
blood
blood
compon
transfus
gener
lifesav
measur
absolut
safeti
never
guarante
addit
immunemedi
reaction
caus
infus
allogen
cell
protein
bloodborn
pathogen
transmit
transfus
potenti
caus
diseas
transfus
recipi
effort
minim
pathogen
transmiss
blood
donor
appropri
screen
infecti
agent
follow
recommend
base
inform
avail
time
write
clariti
consensu
panel
subdivid
pathogen
follow
categori
dog
cat
vectorborn
pathogenstest
recommend
non
vectorborn
pathogenstest
recommend
pathogenstest
recommend
pathogen
test
recommend
met
least
three
follow
criteria
pathogen
document
caus
clinic
infect
recipi
blood
transmiss
pathogen
capabl
caus
subclin
infect
carrier
might
inadvert
identifi
healthi
blood
donor
pathogen
detect
use
cultur
molecular
method
blood
infect
anim
result
infect
recipi
potenti
caus
lifethreaten
ill
difficult
elimin
antimicrobi
drug
use
optim
standard
tabl
see
test
also
recommend
pathogen
experiment
transmit
blood
transfus
even
though
clinic
ill
transfus
describ
panel
separ
screen
recommend
optim
minim
standard
area
endem
ixod
spp
identif
seroneg
donor
may
difficult
therefor
use
seroposit
pcr
neg
dog
donor
consid
accept
situat
seroneg
dog
rare
pcr
posit
serolog
test
alon
could
consid
serolog
test
econom
yield
rapid
turnaround
time
pcr
seroneg
pcr
neg
dog
pcr
neg
dog
seroneg
dog
accept
altern
serolog
test
econom
yield
rapid
turnaround
time
pcr
area
endem
rhipicephalu
tick
spp
identif
seroneg
donor
may
difficult
therefor
use
seroposit
pcr
neg
dog
donor
consid
accept
situat
seroneg
dog
rare
pcr
posit
serolog
test
alon
could
consid
serolog
test
econom
yield
rapid
turnaround
time
pcr
serolog
assay
known
detect
plati
antibodi
minim
standard
pcr
seroneg
pcr
neg
especi
high
risk
dog
pcr
neg
high
risk
dog
includ
greyhound
histori
exposur
rhipicephalu
tick
continu
continu
includ
text
tabl
recommend
made
use
avail
evid
human
veterinari
medic
literatur
evid
lack
combin
opinion
clinic
experi
panel
member
use
develop
recommend
goal
optim
standard
minim
risk
best
abil
applic
current
avail
diagnost
test
howev
panel
acknowledg
applic
diagnost
test
might
relev
geograph
locat
donor
background
eg
breed
environ
diagnost
test
limit
avail
could
cost
prohibit
program
therefor
minim
standard
develop
take
account
factor
case
approach
unfortun
could
result
movement
infect
anim
donor
pool
panel
also
discuss
altern
accept
strategi
geograph
region
preval
infect
may
high
identif
suitabl
donor
difficult
well
screen
potenti
donor
blood
requir
emerg
situat
time
permit
thorough
screen
donat
appar
healthi
donor
may
accept
situat
given
low
risk
transmiss
infect
weigh
alongsid
high
risk
death
recipi
absenc
blood
product
transfus
howev
preemptiv
identif
screen
healthi
blood
donor
remain
import
strategi
safe
blood
bank
human
blood
collect
individu
unit
whole
blood
collect
transfus
purpos
typic
screen
infecti
agent
contrast
econom
factor
veterinari
medicin
often
limit
test
blood
donor
anim
consensu
panel
recommend
minimum
yearli
test
blood
donor
consider
frequent
retest
pathogen
endem
area
donor
repeat
exposur
risk
factor
eg
tick
exposur
consensu
panel
agre
prevent
infect
proper
handl
storag
blood
product
techniqu
also
consid
recommend
includ
consensu
statement
screen
blood
donor
alway
follow
thorough
histori
physic
examin
evalu
factor
may
make
anim
poor
blood
donor
choic
see
donor
select
care
section
test
infecti
agent
analyt
clinic
sensit
specif
screen
bloodborn
pathogen
potenti
blood
donor
test
test
greatest
analyt
sensit
use
howev
situat
preval
infect
low
case
pathogen
healthi
anim
compar
sick
anim
posit
result
like
repres
fals
posit
region
high
preval
low
posit
predict
valu
consider
given
verifi
posit
result
second
test
prefer
use
refer
laboratori
also
test
decis
base
valu
individu
test
given
pathogen
rather
choos
test
simpli
present
blood
donor
panel
offer
commerci
laboratori
follow
brief
discuss
basic
util
limit
test
light
microscopi
document
infecti
agent
blood
smear
cytolog
examin
requir
skill
personnel
time
consum
adequ
blood
film
examin
take
minut
lack
sensit
pathogen
fals
posit
also
occur
stain
artifact
confus
microorgan
therefor
cytolog
examin
blood
smear
recommend
sole
mean
screen
blood
donor
infect
cultur
posit
blood
cultur
result
indic
presenc
cultiv
bacteria
blood
although
transient
bacteremia
occur
healthi
anim
disrupt
mucos
barrier
transfus
blood
anim
transient
bacteremia
document
caus
diseas
recipi
therefor
routin
blood
cultur
gener
indic
screen
potenti
blood
donor
rare
except
see
bartonella
section
transfus
medicin
routin
serum
antigen
test
assay
detect
antigen
sever
bloodborn
pathogen
whole
blood
serum
commerci
avail
dirofilaria
immiti
dog
cat
felin
leukemia
viru
felv
antigen
test
use
frequent
donor
screen
health
assess
pointofcar
test
avail
organ
potenti
inaccur
result
oper
error
small
molecular
assay
immun
system
gener
clear
nonviabl
microb
quickli
amplif
specif
microbi
nucleic
acid
use
assay
like
polymeras
chain
reaction
pcr
gener
indic
presenc
viabl
microb
provid
laboratori
qualiti
assur
high
techniqu
provid
high
analyt
sensit
specif
potenti
rapidli
test
pathogen
disadvantag
includ
current
lack
pointofcar
nucleic
acidbas
assay
veterinari
medicin
lack
standard
assay
among
laboratori
result
variabl
sensit
specif
lack
assay
avail
infecti
agent
expens
also
high
analyt
sensit
pcr
assay
necessarili
impli
high
clinic
sensit
word
assay
may
detect
minut
quantiti
dna
laboratori
poor
sensit
detect
pathogen
blood
specimen
pcr
assay
util
blood
anim
receiv
time
volum
transfus
although
molecular
assay
high
analyt
sensit
assay
amplifi
microb
specimen
collect
thu
fals
neg
result
occur
agent
found
low
quantiti
bloodstream
ehrlichia
cani
felin
immunodefici
viru
fiv
anim
overt
microscop
evid
infect
cultureposit
antigenposit
posit
pcr
assay
clinic
relev
bloodborn
pathogen
exclud
donor
pool
whether
pathogen
caus
chronic
persist
infect
elimin
antimicrobi
therapi
certain
anim
histori
previou
posit
test
result
pathogen
use
blood
donor
posit
serum
antibodi
assay
result
suggest
previou
infect
pathogen
question
prove
current
infect
neg
result
antibodi
test
gener
suggest
lack
infect
serum
antibodi
undetect
even
presenc
activ
infect
situat
like
common
antibodi
test
perform
acut
stage
infect
well
document
sever
vectorborn
pathogen
see
ehrlichia
anaplasma
section
agent
bartonella
stealth
organ
evad
immun
system
may
induc
detect
serum
antibodi
sever
immunocompromis
anim
also
may
fail
mount
specif
antibodi
respons
eg
cat
advanc
fiv
infect
dog
cat
gener
ill
hope
would
exclud
donor
pool
base
find
pointofcar
assay
avail
detect
antibodi
respons
pathogen
advantag
rapid
inexpens
potenti
oper
error
assay
small
standard
serolog
test
offer
commerci
laboratori
infecti
agent
avail
differ
antigen
antigen
prepar
reagent
protocol
influenc
result
serolog
assay
among
laboratori
pointofcar
assay
addit
inher
subject
interpret
immunofluoresc
antibodi
ifa
assay
problemat
pathogen
combin
serolog
organ
demonstr
techniqu
cytolog
cultur
pcr
may
requir
maxim
diagnosi
infect
canin
bloodborn
pathogen
dirofilaria
immiti
meet
criteria
use
categor
vectorborn
pathogen
transfus
microfilaria
infect
donor
lead
heartworm
diseas
recipi
howev
filarem
blood
transfus
recipi
potenti
interfer
diagnost
test
infecti
mosquito
vector
carri
wolbachia
spp
addit
donor
infect
immiti
would
consid
healthi
donor
collect
larg
amount
blood
donor
could
unsaf
therefor
recommend
dog
cat
use
blood
donor
heartworm
endem
area
screen
immiti
infect
place
heartworm
prophylaxi
anaplasma
spp
phagocytophilum
plati
caus
agent
canin
granulocyt
anaplasmosi
infecti
canin
cyclic
thrombocytopenia
respect
transmiss
phagocytophilum
occur
via
ixod
scapulari
ixod
pacificu
tick
unit
state
widespread
subclin
infect
follow
pathogen
clearanc
appear
common
human
dog
pathway
transmiss
via
infect
blood
either
experiment
blood
transfus
human
medicin
sever
report
transfusiontransmiss
phagocytophilum
via
differ
blood
product
nonleukoreducedleukoreduc
rbc
leukoreduc
platelet
also
transfusiontransmit
granulocyt
anaplasmosi
document
widespread
subclin
infect
follow
pathogen
clearanc
appear
common
human
dog
immunocompromis
elderli
peopl
infect
caus
sever
diseas
donat
screen
inactiv
pathogen
reduct
technolog
consid
human
medicin
anaplasmosi
occur
splenectom
dog
chemotherapi
pack
rbc
transfus
donor
recipi
test
posit
pcr
kohn
unpublish
data
pcr
posit
dog
seroneg
clinic
hematolog
variabl
within
refer
interv
antibodi
anaplasma
speci
detect
use
ifa
assay
autom
fluorescencebas
system
pointofcar
later
flow
elisa
assay
laboratorybas
elisa
assay
serolog
crossreact
among
anaplasma
speci
occur
assay
tabl
seropreval
ifa
elisa
high
endem
area
antibodi
titer
may
persist
sever
month
even
year
extent
phagocytophilum
persist
tissu
contribut
chronic
diseas
manifest
human
dog
current
unknown
studi
treatment
experiment
infect
dog
prednisolon
month
infect
follow
develop
posit
pcr
result
organ
dog
thrombocytopenia
reappear
morula
blood
smear
anoth
studi
dog
infect
phagocytophilum
exposur
wildcaught
ixod
scapulari
tick
pcr
posit
least
week
light
inform
panel
recommend
optim
standard
screen
donor
use
serolog
pcr
dog
test
posit
assay
exclud
exclus
seroposit
dog
might
limit
donor
pool
endem
area
see
comment
tabl
anaplasma
plati
thought
transmit
rhipicephalu
sanguineu
infect
common
region
endem
tick
anaplasma
plati
establish
chronic
persist
subclin
infect
sometim
accompani
mild
thrombocytopenia
dog
infect
experiment
blood
develop
sever
thrombocytopenia
within
day
inocul
transfusiontransmit
infect
diseas
report
neither
human
dog
ifa
assay
detect
serum
antibodi
commerci
avail
crossreact
occur
phagocytophilum
speciesspecif
pcr
test
blood
sampl
diagnost
method
choic
assay
phagocytophilum
antibodi
may
may
detect
plati
antibodi
tabl
donor
dog
neg
antibodi
neg
use
speciesspecif
pcr
optim
tabl
babesia
spp
babesiosi
caus
organ
genu
babesia
babesia
cani
voge
babesia
gibsoni
common
speci
diagnos
north
american
dog
sever
babesia
spp
identifi
dog
north
america
babesia
sp
coco
babesia
conrada
part
world
b
cani
b
rossi
b
microtilik
unnam
babesia
sp
transmiss
babesia
spp
transfus
well
document
human
dog
result
diseas
dog
peracut
acut
chronic
subclin
high
seropreval
b
cani
occur
greyhound
increas
preval
b
gibsoni
occur
american
pit
bull
terrier
american
staffordshir
terrier
detect
pcr
optim
screen
includ
serolog
b
voge
b
gibsoni
broad
rang
pcr
screen
ie
detect
known
babesia
spp
infect
dog
minim
screen
may
includ
broadrang
pcr
screen
pit
bull
type
dog
greyhound
dog
known
tick
exposur
dog
bite
exposur
pit
bull
type
dog
addit
pcr
screen
consid
beyond
optim
recommend
enhanc
sensit
bartonella
spp
dog
infect
sever
bartonella
spp
proven
suspect
vector
flea
potenti
tick
bartonella
vinsonii
subspeci
berkhoffi
b
rochalima
common
speci
amplifi
dog
flea
shelter
florida
bartonella
hensela
common
cat
blood
ctenocephalid
feli
collect
cat
also
grown
amplifi
blood
dog
although
bartonella
spp
transmiss
document
blood
transfus
clientown
dog
clinic
ill
dog
posit
bartonella
spp
detect
healthi
dog
harbor
bartonella
spp
organ
transmit
inocul
thu
plausibl
bartonella
spp
could
transmit
blood
transfus
result
clinic
ill
panel
therefor
believ
test
indic
genu
valid
serolog
assay
pcr
assay
cultur
avail
b
hensela
b
vinsonii
subspeci
berkhoffi
like
pathogen
dog
tabl
sensit
way
document
bartonella
spp
blood
dog
concurr
use
special
cultur
media
bartonella
alpha
proteobacteria
growth
medium
bapgm
pcr
assay
multipl
blood
sampl
combin
test
detect
known
bartonella
spp
dog
howev
bapgmpcr
neg
even
infect
dog
sampl
test
panel
believ
optim
standard
use
b
hensela
b
vinsonii
subspeci
berkhoffi
seroneg
bapgmpcr
neg
dog
donor
tabl
canin
blood
donor
candid
studi
although
screen
dog
posit
bartonella
spp
seroposit
addit
serolog
crossreact
variabl
among
bartonella
spp
assay
routin
avail
speci
thu
panel
believ
bartonella
spp
serum
antibodi
test
alon
use
exclus
assess
dog
use
blood
donor
sever
laboratori
offer
broad
rang
pcr
assay
amplifi
dna
multipl
bartonella
spp
offer
specif
primer
b
hensela
b
vinsonii
subspeci
berkhoffi
tabl
test
serolog
bapgm
culturepcr
practic
expens
turnaround
time
panel
believ
minim
standard
use
dog
pcr
neg
dna
b
hensela
b
vinsonii
subspeci
berkhoffi
ehrlichia
spp
ehrlichia
cani
e
ewingii
e
chaffeensi
vectorborn
agent
belong
famili
rickettsiacea
capabl
caus
diseas
dog
pathogen
e
cani
greatest
import
blood
donor
screen
high
preval
worldwid
propens
caus
chronic
persist
infect
recent
studi
suggest
e
ewingii
also
capabl
caus
persist
infect
dog
restrict
geograph
distribut
experi
tabl
laboratori
offer
point
care
laboratorybas
assay
potenti
use
screen
blood
donor
laboratori
select
inclus
either
provid
standard
oper
procedur
critic
review
publish
peer
review
articl
document
qualiti
control
assay
specif
standard
oper
procedur
monitor
stateaccredit
laboratori
laboratori
produc
kit
licens
usda
laboratori
panel
member
work
directli
provid
evid
qualiti
assur
meant
exhaust
list
mani
laboratori
especi
state
accredit
laboratori
also
provid
qualiti
laboratori
servic
direct
comparison
among
differ
test
infecti
diseas
agent
gener
avail
unless
publish
see
refer
list
main
document
mental
sc
inocul
e
cani
result
dosedepend
infect
posit
blood
cultur
screen
potenti
donor
dog
antibodi
ehrlichia
antigen
perform
ifa
assay
sever
commerci
pointofcar
assay
c
laboratorybas
assay
b
variabl
serolog
crossreact
occur
among
ehrlichia
speci
pointofcar
assay
recombin
peptid
antigen
e
cani
e
ewingii
combin
togeth
singl
spot
posit
result
reflect
either
seroreact
e
cani
e
ewingii
pathogen
sensit
specif
assay
compar
ifa
report
clinic
sensit
specif
avail
assay
requir
studi
serolog
reactiv
e
cani
e
ewingii
e
chaffeensi
variabl
known
assay
infect
document
broadrang
pcr
assay
seroconvers
panel
believ
optim
standard
use
donor
seroneg
pcr
neg
tabl
import
e
cani
import
primari
pathogen
hemoplasma
dog
infect
sever
hemoplasma
speci
includ
mycoplasma
haemocani
candidatu
haematoparvum
possibl
also
candidatu
haemominutum
relat
organ
although
tick
implic
transmiss
haemocani
mechan
transmiss
proven
kennel
dog
research
anim
appear
higher
risk
infect
haemocani
diagnosi
infect
base
pcr
assay
whole
blood
serolog
assay
hemoplasma
infect
commerci
avail
gener
dog
subclin
infect
organ
haemocani
caus
anemia
splenectom
dog
case
report
infect
dog
immunocompromis
comorbid
singl
clinic
infect
candidatu
haematoparvum
report
splenectom
dog
hemic
neoplasia
treat
chemotherapi
unclear
extent
hemoplasma
play
role
develop
anemia
dog
receiv
sever
unit
blood
product
test
posit
use
pcr
candidatu
haematoparvum
test
neg
transfus
syke
et
al
unpublish
data
therefor
optim
donor
dog
screen
hemoplasma
pcr
assay
exclud
posit
tabl
howev
learn
risk
transfus
blood
test
posit
candidatu
haemominutum
candidatu
haematoparvum
test
pathogen
could
consid
option
also
kept
mind
preval
hemoplasma
infect
gener
clientown
pet
dog
popul
north
america
appear
low
whether
viabil
canin
hemoplasma
speci
lost
storag
blood
product
see
felin
hemoplasma
requir
studi
antimicrobi
therapi
reliabl
elimin
hemoplasma
panel
recommend
treat
potenti
donor
antimicrobi
attempt
elimin
infect
hepatozoon
cani
hepatozoon
americanum
hepatozoon
cani
hepatozoon
americanum
tickborn
protozo
pathogen
transmit
primarili
ingest
rhipicephalu
sanguineu
amblyomma
maculatum
tick
respect
north
america
distribut
infect
primarili
limit
southcentr
southeastern
unit
state
occasion
h
americanum
infect
identifi
state
includ
washington
vermont
california
nebraska
h
cani
infect
subclin
h
americanum
caus
lethargi
fever
locomotori
abnorm
hyperesthesia
proteinlos
nephropathi
organ
circul
peripher
blood
gamont
leukocyt
report
transmiss
blood
transfus
screen
could
consid
endem
area
use
specif
pcr
assay
h
cani
h
americanum
serolog
assay
routin
diagnost
purpos
avail
north
america
leishmania
spp
leishmaniosi
caus
protozo
organ
genu
leishmania
transmit
mediterranean
region
bite
infect
femal
sandfli
vector
north
america
known
lutzomyia
shannoni
highli
suspect
vector
unit
state
dogtodog
transmiss
also
hypothes
viscer
leishmaniosi
caus
leishmania
donovani
consid
exot
diseas
dog
north
america
except
foxhound
popul
endem
dog
north
america
also
acquir
infect
travel
foreign
countri
month
year
diagnosi
viscer
leishmaniosi
transmit
blood
transfus
dog
clinic
healthi
foxhound
blood
donor
retrospect
studi
perform
serum
sampl
foxhound
canid
unit
state
report
seropreval
foxhound
randomli
select
domest
dog
wild
canid
seroposit
infect
appear
endem
within
foxhound
north
america
screen
everi
potenti
blood
donor
necessari
howev
foxhound
dog
travel
histori
endem
countri
screen
leishmania
spp
infect
use
ifa
serolog
perform
reput
laboratori
ifa
serolog
may
lack
sensit
subclin
infect
dog
foxhound
dog
live
travel
endem
area
found
seroneg
screen
addit
leishmania
pcr
ifa
assay
leishmania
spp
crossreact
trypanosoma
cruzi
although
dog
either
infect
exclud
blood
donor
leishmania
spp
seroposit
dog
evalu
presenc
specif
antibodi
cruzi
clinic
inform
desir
neorickettsia
risticii
dog
experiment
infect
n
risticii
antibodi
n
risticii
detect
pet
dog
polymeras
chain
reaction
use
studi
identifi
n
risticii
obtain
blood
cultur
clinic
ill
dog
document
transmiss
n
risticii
dog
blood
transfus
although
committe
believ
optim
dog
test
pcrneg
neorickettsia
risticii
infect
screen
also
accept
rickettsia
feli
rickettsia
feli
member
spot
fever
group
rickettsia
dog
unit
state
agent
like
induc
serolog
cross
reactiv
r
rickettsii
assay
current
assum
agent
associ
ill
dog
studi
need
evid
dog
reservoir
r
feli
ctenocephalid
feli
collect
cat
unit
state
commonli
posit
r
feli
dna
current
unknown
whether
transfus
larg
volum
blood
r
feli
carrier
dog
ill
dog
need
transfus
would
clinic
sequela
pcr
assay
way
current
prove
r
feli
infect
dog
although
panel
believ
optim
dog
test
pcrneg
r
feli
infect
screen
also
accept
tabl
trypanosoma
cruzi
american
trypanosomiasi
chaga
diseas
caus
trypanosoma
cruzi
hemoflagel
protozoan
transmiss
commonli
occur
fecescontamin
bite
ingest
triatomin
bug
vector
small
number
transfusionacquir
cruzi
infect
report
peopl
north
america
patient
immunocompromis
time
infect
donor
countri
cruzi
endem
south
central
america
food
drug
administr
recommend
present
human
blood
donor
ask
histori
chaga
diseas
addit
test
least
use
licens
screen
test
infect
dog
result
acut
chronic
myocard
studi
dog
experiment
inocul
cruzi
parasitem
develop
transient
lymphadenopathi
survivor
acut
diseas
remain
subclin
infect
sever
month
chronic
myocard
develop
infect
character
detect
concentr
specif
antibodi
low
concentr
circul
parasit
dog
develop
trypanosomiasi
unit
state
resid
texa
southwestern
state
seropreval
studi
dog
shelter
divers
ecoregion
texa
transmiss
dog
blood
transfus
report
dog
histori
travel
endem
area
texa
new
mexico
arizona
southern
california
mexico
central
america
south
america
consid
serolog
screen
ifa
indirect
hemagglutin
assay
iha
elisa
immunochromatograph
dipstick
test
seroposit
donor
exclud
donor
pool
serolog
crossreact
cruzi
leishmania
spp
document
pcr
assay
detect
cruzi
whole
blood
also
could
consid
non
vectorborn
pathogenstest
recommend
brucella
cani
brucella
cani
zoonot
pathogen
gramneg
bacterium
caus
brucellosi
dog
vener
transmiss
occur
breed
transmiss
follow
oronas
contact
vagin
discharg
abort
materi
urin
infect
dog
human
transfusiontransmit
brucella
infect
document
worldwid
transmiss
b
cani
blood
transfus
document
dog
howev
infect
associ
prolong
bacteremia
may
subclin
thu
potenti
transmiss
transfus
exist
commerci
avail
result
obtain
minut
serolog
screen
potenti
donor
antibodi
use
rapid
slide
agglutin
test
rsat
initi
recommend
e
posit
dog
exclud
blood
donor
addit
confirmatori
diagnost
assay
perform
use
blood
cultur
pcr
whole
blood
tube
agglutin
test
agaros
gel
immunodiffus
test
elisa
test
singl
neg
rsat
suffici
neuter
donor
meet
optim
standard
rsat
screen
repeat
sexual
activ
intact
dog
approach
support
numer
studi
conclud
rsat
highli
sensit
lack
specif
recent
studi
pcr
assay
perform
whole
blood
genitourinari
secret
found
sensit
serolog
test
notabl
earli
phase
infect
pathogenstest
recommend
borrelia
burgdorferi
lyme
borreliosi
caus
spirochet
borrelia
burgdorferi
vector
ixod
spp
mani
dog
northeastern
upper
midwest
region
unit
state
seroposit
small
percentag
dog
develop
polyarthr
nephriti
transfusionrel
infect
report
despit
abil
cultur
b
burgdorferi
human
blood
studi
human
demonstr
risk
acquir
lyme
diseas
transfus
unit
pack
red
blood
cell
platelet
neglig
studi
dog
blood
sampl
experiment
infect
dog
test
posit
b
burgdorferi
pcr
consensu
panel
healthi
canin
blood
donor
screen
b
burgdorferi
screen
test
b
detect
seroreact
pathogen
use
donor
seroposit
b
burgdorferi
anim
need
exclud
donor
pool
neorickettsia
helminthoeca
test
blood
donor
dog
n
helminthoeca
recommend
pathogen
produc
acut
diseas
without
evid
carrier
state
healthi
dog
without
evid
bloodborn
transmiss
rickettsia
rickettsii
rocki
mountain
spot
fever
rmsf
caus
rickettsia
rickettsii
acut
system
infect
vascular
endotheli
cell
organ
rapidli
elimin
dog
surviv
clinic
ill
chronic
carrier
state
report
consensu
panel
healthi
blood
donor
need
screen
antibodi
r
rickettsii
infect
dog
acut
ill
subclin
carrier
state
known
exist
dog
seroposit
rickettsia
spp
need
exclud
blood
donor
west
nile
viru
west
nile
viru
wnv
mosquitoborn
zoonot
arboviru
genu
flaviviru
infect
human
asymptomat
mild
diseas
character
fever
headach
muscl
ach
skin
rash
meningoenceph
develop
case
although
dog
becom
virem
infect
wnv
typic
develop
subclin
viremia
low
magnitud
follow
clearanc
viru
rare
report
clinic
diseas
exist
therefor
canin
blood
donor
need
test
wnv
vectorborn
pathogenstest
recommend
anaplasma
spp
cat
phagocytophilum
infect
develop
mild
clinic
ill
resolv
quickli
administr
doxycyclin
research
cat
infest
fieldcaught
scapulari
endem
area
becom
pcr
posit
seroconvers
develop
antibodi
detect
commerci
avail
assay
use
dog
sera
maintain
rickettsemia
week
administr
doxycyclin
addit
cat
phagocytophilum
infect
morula
visual
cytolog
cytoplasm
neutrophil
organ
caus
ill
cat
transmit
experiment
blood
inocul
result
persist
infect
associ
ill
panel
recommend
optim
healthi
cat
endem
area
screen
phagocytophilum
infect
serolog
pcr
neg
test
tabl
howev
endem
area
seroposit
cat
may
common
limit
blood
donor
pool
thu
committe
believ
blood
donor
cat
phagocytophilum
seroneg
pcr
neg
avail
cat
phagocytophilum
seroposit
pcr
cultur
neg
could
use
tabl
infect
cat
plati
occasion
document
cat
live
area
endem
rhipicephalu
spp
tick
screen
pcr
tabl
bartonella
spp
number
bartonella
spp
grown
amplifi
blood
cat
commonli
b
hensela
b
clarridgeia
b
koehlera
b
quintana
cat
reservoir
ctenocephalid
feli
vector
b
hensela
b
clarridgeia
b
koehlera
agent
extrem
common
blood
cat
flea
bartonella
hensela
appear
like
pathogen
studi
need
determin
diseas
associ
speci
bartonella
hensela
infect
document
pcr
assay
commun
sourc
cat
use
blood
donor
unit
state
like
reflect
use
flea
control
product
infect
cat
typic
prolong
subclin
bacteremia
number
clinic
sequela
also
occur
bartonella
spp
transmit
blood
transfus
store
blood
inactiv
organ
f
sensit
way
document
bartonella
spp
blood
cat
concurr
use
special
cultur
media
pcr
assay
use
sever
blood
sampl
although
approach
frequent
need
prove
presenc
bartonella
spp
blood
clinic
ill
dog
whether
increas
sensit
need
screen
cat
use
blood
donor
remain
proven
cat
definit
host
b
hensela
high
level
bacteremia
often
detect
even
cat
healthi
thu
broad
rang
pcr
assay
pcr
assay
use
specif
primer
use
wide
commerci
laboratori
unit
state
like
detect
infect
cat
tabl
bacteremia
cat
infect
b
hensela
exposur
infect
c
feli
preced
seroconvers
day
thu
serolog
alon
inadequ
screen
test
howev
immun
respons
develop
bacteremia
intermitt
cat
fals
neg
result
could
occur
singl
sampl
assay
thu
panel
recommend
optim
standard
use
cat
seroneg
pcr
assay
cultur
neg
tabl
major
state
unit
state
endem
c
feli
bartonella
spp
seropreval
rate
high
thu
mani
state
requir
communitybas
blood
donor
cat
bartonella
spp
seroneg
pcr
cultur
neg
could
make
difficult
find
adequ
number
donor
although
seroposit
mani
healthi
cat
infect
b
henselaeinfect
c
feli
limit
bacteremia
time
thu
panel
believ
minim
standard
use
bartonella
spp
pcr
neg
cat
tabl
use
antibiot
consist
elimin
bartonella
spp
infect
cat
thu
pcr
cultur
posit
cat
exclud
blood
donor
program
cytauxzoon
feli
cytauxzoon
feli
tickborn
protozo
pathogen
order
piroplasmida
famili
theileriida
section
cytauxzoonosi
use
denot
acut
ill
ie
system
inflammatori
respons
syndrom
cytopenia
multiorgan
failur
associ
c
feli
infect
tick
transmiss
organ
undergo
schizogoni
myeloid
cell
specif
lineag
unknown
follow
merogoni
erythrocyt
schizogen
stage
associ
ill
diseas
transmit
experiment
transmiss
blood
cat
cytauxzoonosi
naiv
cat
major
cat
cytauxzoonosi
present
veterinari
hospit
develop
sever
febril
ill
cytopenia
often
die
within
day
present
appropri
treatment
given
carrier
state
erythrocyt
infect
identifi
associ
clinic
diseas
fact
transfus
blood
chronic
infect
cat
naiv
cat
result
ill
theoret
risk
transmiss
cytauxzoonosi
exist
parasitemia
preced
ill
experiment
infect
parasit
dna
detect
earli
day
postinfect
clinic
sign
begin
day
postinfect
serolog
assay
avail
use
indoor
cat
receiv
appropri
ectoparasit
prophylaxi
advis
avoid
diseas
donor
anim
appropri
donor
select
predon
physic
examin
minim
transmiss
risk
panel
recommend
optim
standard
use
pcr
neg
cat
endem
area
tabl
ehrlichia
cani
clientown
cat
clinic
sign
diseas
document
e
cani
e
canislik
organ
dna
blood
studi
evalu
e
cani
e
canislik
organ
healthi
cat
unit
state
yield
neg
result
thu
although
committe
believ
optim
cat
test
pcrneg
ehrlichia
spp
infect
screen
also
accept
tabl
hemoplasma
hemoplasmosi
felin
infecti
anemia
caus
mycoplasma
haemof
speci
hemoplasma
infect
cat
north
america
candidatu
haemominutum
mhm
candidatu
turicensi
mtc
organ
substanti
less
pathogen
frequent
detect
preval
use
pcr
blood
nonanem
clientown
pet
cat
either
appar
healthi
brought
veterinari
clinic
reason
anemia
contrast
north
america
haemof
rare
detect
nonanem
cat
use
pcr
cat
chronic
infect
candidatu
haemominutum
splenectom
concurr
treat
high
dose
glucocorticoid
persist
subclin
infect
occur
absenc
anemia
although
flea
suggest
involv
transmiss
evid
fleaborn
transmiss
weak
epidemiolog
evid
suggest
aggress
interact
cat
may
lead
transmiss
intraven
inocul
infect
blood
use
produc
experiment
infect
serolog
assay
infect
commerci
avail
blood
smear
evalu
insensit
especi
chronic
carrier
cat
also
lack
specif
organ
easili
confus
stain
precipit
dri
artifact
thu
diagnost
test
choic
screen
blood
donor
pcr
pathogen
haemof
panel
agre
cat
test
haemof
test
posit
exclud
blood
donor
pool
optim
cat
test
candidatu
haemominutum
candidatu
turicensi
exclud
donor
pool
given
high
preval
organ
cat
popul
lack
strong
evid
associ
diseas
even
immunosuppress
cat
panel
agre
screen
pathogen
could
consid
option
posit
cat
could
use
donor
absenc
sourc
neg
blood
tabl
antimicrobi
therapi
reliabl
elimin
hemoplasma
appear
particularli
ineffect
treatment
candidatu
haemominutum
infect
panel
recommend
treat
potenti
donor
antimicrobi
attempt
elimin
infect
importantli
haemof
appear
inactiv
storag
whole
blood
week
candidatu
haemominutum
may
remain
viabl
blood
product
week
although
inactiv
appear
occur
month
storag
neorickettsia
risticii
infect
cat
experiment
inocul
detect
natur
expos
cat
although
committe
believ
optim
cat
test
pcrneg
neorickettsia
risticii
infect
screen
also
accept
tabl
felin
leukemia
viru
transmiss
felin
leukemia
viru
felv
occur
primarili
saliva
viru
present
blood
transmit
blood
transfus
screen
donor
cat
felv
use
elisa
detect
solubl
circul
core
viral
antigen
peripher
blood
recommend
cat
test
antigenposit
exclud
blood
donor
recognit
cat
expos
felv
develop
regress
infect
defin
transient
undetect
antigenemia
provir
dna
blood
optim
realtim
pcr
test
provir
dna
perform
felv
proviru
infecti
howev
pcr
assay
felv
provir
dna
current
avail
unit
state
evalu
clinic
sensit
specif
regressor
cat
detect
provir
dna
viral
rna
mani
tissu
includ
bone
marrow
mani
year
felv
exposur
indic
cat
complet
clear
viru
regressor
cat
transmit
felv
infect
recipi
cat
blood
transfus
recipi
go
develop
progress
infect
g
furthermor
reactiv
felv
infect
regressor
cat
without
immun
suppress
report
reactiv
regress
felv
infect
potenti
place
felvneg
donor
cat
risk
hous
togeth
coloni
situat
reactiv
occur
interv
routin
screen
test
eg
annual
screen
detect
freeroam
cat
constant
potenti
exposur
exclud
blood
donor
program
felin
immunodefici
viru
felin
immunodefici
viru
fiv
transmit
primarili
bite
wound
readili
transmit
via
inocul
infect
blood
test
donor
cat
fivspecif
antibodi
elisa
use
immobil
fiv
core
protein
gag
captur
antibodi
blood
recommend
seroposit
cat
exclud
donor
pool
cat
vaccin
fiv
also
seroposit
definit
differenti
infect
vaccin
cat
challeng
viru
isol
gold
standard
diagnosi
fiv
infect
timeconsum
expens
realtim
quantit
pcr
assay
fiv
moder
sensit
highli
specif
fiv
infect
posit
result
occur
uninfect
vaccin
cat
therefor
reliabl
approach
avail
conclus
discrimin
natur
infect
cat
vaccin
cat
panel
recommend
seroposit
cat
includ
vaccin
cat
exclud
donor
pool
freeroam
cat
also
exclud
donor
program
pathogenstest
recommend
felin
coronaviru
although
cat
subclin
infect
felin
coronaviru
document
transmiss
viru
blood
transfus
exist
time
screen
blood
donor
cat
serolog
revers
transcriptas
rt
pcr
recommend
healthi
cat
antibodi
titer
felin
coronaviru
also
rtpcr
posit
consensu
panel
screen
coronaviru
antibodi
rna
clinic
healthi
cat
consid
blood
donor
rickettsia
feli
dog
recent
document
reservoir
agent
studi
fail
amplifi
r
feli
dna
blood
cat
thu
panel
recommend
screen
organ
cat
toxoplasmosi
cat
definit
host
toxoplasma
gondii
intracellular
coccidian
parasit
although
toxoplasma
gondii
antigen
dna
detect
healthi
cat
pcr
assay
transmiss
blood
transfus
document
purpos
blood
safeti
consensu
panel
indic
screen
healthi
potenti
donor
cat
gondii
antigen
antibodi
dna
tabl
present
current
recommend
blood
donor
screen
consensu
panel
hope
find
lead
reevalu
current
infecti
diseas
screen
process
potenti
canin
felin
donor
diagnost
laboratori
reexamin
donor
screen
panel
offer
assay
pathogen
concern
bloodborn
diseas
transmiss
panel
agre
sever
manag
techniqu
design
decreas
risk
diseas
transmiss
blood
transfus
standard
form
tabl
complet
enrol
potenti
blood
donor
donat
complet
histori
thorough
physic
examin
includ
determin
rectal
temperatur
donor
anim
complet
blood
collect
use
antimicrobi
drug
prevent
treat
possibl
infect
accept
substitut
laboratori
test
potenti
blood
donor
initi
clinicopatholog
screen
potenti
donor
advis
eg
cbc
serum
biochemistri
urinalysi
fecal
examin
determin
pcv
advis
collect
blood
collect
procedur
recommend
blood
transfus
collect
asept
manner
administr
label
blood
product
examin
follow
collect
expir
date
donor
speci
product
type
blood
type
administr
blood
product
visual
inspect
bacteri
contamin
suspect
bag
segment
appear
much
lighter
color
bag
red
blood
cell
mass
appear
purpl
zone
hemolysi
observ
red
cell
mass
clot
visibl
plasma
supernat
fluid
murki
purpl
brown
red
presenc
find
cultur
blood
perform
determin
whether
contamin
occur
unit
appear
abnorm
administ
current
screen
individu
unit
infecti
diseas
practic
veterinari
medicin
turnaround
time
cost
test
howev
model
consid
gold
standard
aliquot
plasma
whole
blood
tube
segment
donat
unit
blood
store
practic
allow
retrospect
test
case
suspect
transfusionassoci
diseas
transmiss
record
kept
transfus
document
donor
unit
use
recipi
transfus
appropri
record
must
kept
recipi
receiv
blood
given
donor
easili
contact
donor
found
carri
infecti
diseas
agent
develop
consent
form
detail
potenti
diseas
transmiss
risk
consid
owner
patient
receiv
transfus
thousand
blood
transfus
perform
year
dog
cat
demand
blood
product
continu
grow
risk
associ
transfus
includ
risk
diseas
transmiss
appropri
screen
blood
donor
bloodborn
infecti
diseas
agent
perform
decreas
risk
geograph
restrict
comfort
area
hair
clip
cat
neck
n
clip
necessari
procedur
asept
prepar
area
venipunctur
comfort
sedat
andor
anesthesia
cat
n
necessari
procedur
prior
blood
collect
donor
cat
